drugset / Trial / NCT01421693

Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever

NCT01421693

RandomizedParallel-groupOpen-labelTreatment

Summary

The investigators aim to compare two antibiotic treatments for enteric (typhoid) fever. Three hundred patients at Patan Hospital will be enrolled in the study. Patients will be assigned to one of the two treatments by chance and followed for 6 months. The two treatment groups will be compared to see which treatment is more likely to make the patient better.

Timeline

Start
2011-09
Primary completion
2014-07
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ceftriaxone Other / unclassified 60 mg/kg Intravenous
Comparator Ceftriaxone Other / unclassified 2 g Intravenous
Comparator Gatifloxacin Small molecule 10 mg/kg Oral

Indications